Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06219317
Title Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC (ICARS)
Acronym ICARS
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ITA | FRA | ESP | BEL

Facility Status City State Zip Country Details
Cliniques Universitaires Saint-Luc Brussels Belgium Details
CHU Helora Pole Hospitalier Jolimont Haine-Saint-Paul Belgium Details
CHU Mont Godinne - UCL Namur Yvoir Belgium Details
CH de La Cote Basque - Saint Leon Bayonne France Details
Institut Paoli-Calmettes Marseille France Details
Groupe Hospitalier Paris Saint Joseph Paris France Details
ASST Ovest Milanese - Legnano Legnano Italy Details
Azienda Unita Locale Socio-Sanitaria N. 9-Mater Salutis Hospital Legnano Italy Details
Fondazione IRCCS - Policlinico San Matteo Pavia Italy Details
AUSL Della Romagna - Ospedale Santa Maria delle Croci Ravenna Italy Details
Istituto Clinico Humanitas Rozzano Italy Details
Azienda Ospedaliero - Universitaria "Santa Maria della Misericordia" di Udine Udine Italy Details
Academisch Ziekenhuis Maastricht Maastricht Netherlands Details
Hospital De La Santa Creu I Sant Pau Barcelona Spain Details
UOMi Cancer Center Barcelona Spain Details
Hospital Quironsalud Sagrado Corazon Sevilla Spain Details
University Hospital Virgen del Rocio Sevilla Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field